InspireMD Announces First U.S. Commercial TCAR Procedures Using the FDA-Approved CGuard® Prime TransCarotid Stent SystemGlobeNewsWire • Wednesday
InspireMD to Host KOL Webinar on Carotid Artery Disease Management and the Clinical Benefits of InspireMD's CGuard Prime Carotid Stent PlatformGlobeNewsWire • Tuesday
InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026GlobeNewsWire • Monday
InspireMD Announces FDA Approval of the CGuard® Prime TransCarotid Stent System for Transcarotid Artery Revascularization (TCAR) ProceduresGlobeNewsWire • 11/12/26
InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 MillionGlobeNewsWire • 09/21/26
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewsWire • 09/03/26
InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and MarketingGlobeNewsWire • 07/30/26
InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCARZacks Investment Research • 06/16/26
InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR ProceduresGlobeNewsWire • 06/11/26
InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR ProceduresGlobeNewsWire • 06/08/26
InspireMD, Inc. (NSPR) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks TranscriptSeeking Alpha • 05/14/26
InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare ConferenceGlobeNewsWire • 05/06/26